Bioxyne Limited (BXN)

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today Ľ it's FREE! Already a member? Login now!

General Information
Company Name: Bioxyne Limited
Stock Code: BXN
GICS Sub-Industry: Biotechnology
Market Cap ($M): 3
Equiv. Shares (M): 200

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.016 $ 0.000 $ 0.000 $ 0.000 $ 0.016 0 0%

Company Overview

Business Description:
Bioxyne Limited (BXN) is a biopharmaceutical company focused on respiratory disease. The principal activities of the Company consisted of the research and development of products for the ongoing treatment of Chronic Obstructive Pulmonary Disease. The Company’s second core activity is the manufacture and marketing of consumer dietary supplements based on the proprietary probiotic using Lactobacillus fermentum.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2014  A 0.2 0.1 -- 7.7 0.0 0.0 --
2013  A -6.2 -4.0 -- 0.0 0.0 0.0 --
2012  A -0.3 -0.6 -- 0.0 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F 2012 A 2013 F 2014 F
Bionomics (BNO) $257 M -- 6.3247 0.3032 79.8701 10.9043 8.3673 0.00 0.00 0.00
Bioxyne (BXN) $4 M -- -- -- 13.8462 -- -- 0.00 -- --
CSL (CSL) $34,851 M 0.0899 0.1809 0.1250 25.7080 21.7690 19.3497 1.63 1.94 2.13
Mesoblast (MSB) $1,370 M -- -- -- -- -- -- 0.00 0.00 0.00
Sirtex Medical (SRX) $1,221 M 0.2906 0.5104 0.3727 52.3245 34.6425 25.2365 0.65 0.84 1.39

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
BXN 0.82 12.3 3.08 -- 1.27
Market 1.20 13.5 0.99 0.99 3.49
Sector 0.75 22.3 3.06 1.35 8.75

Name Position Start Date
Mr George Cameron-Dow Non-Executive Director 21 July 2014
Mr Patrick Douglas Ford Non-Executive Director 20 May 2005
Mr Anthony Peng Ho Non-Executive Director,Non-Executive Chairman 30 October 2012

Name Position
Jarrod White Chief Financial Officer,Company Secretary

Substantial Shareholders
Holding Name
13,585,626 (8.33%) Wigram Trading Pty Ltd
9,678,085 (5.94%) PT Soho Industri Pharmasi
31,355,427 (19.23%) Phillip Asset Management Ltd
9,564,390 (5.84%) Robert Llewllyn & Christine Mary Clancy

Calendar of Events
Date Event
29 September 2015 Report (Annual)
28 August 2015 Report (Prelim)
27 February 2015 Report (Interim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at


Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Debt Relief

An educational booklet to help you take control of your debts and look to get back on track.

More details...


Billionaires bankroll Ten's new direction Media Network sees digital future

The Age 19/12/2013 | Ten Network's programming ambitions will be funded by a $200 million loan guaranteed by three of its billionaire owners, as the free-to-air broadcaster declared digital was the future and pointed to early signs that its switch to an older market demographic was working.

Elders alleges $24m fraud in live cattle division

The Age 19/12/2013 | Troubled rural services group Elders is threatening to call in the police over an alleged $24 million fraud by a "handful of individuals" in its live cattle exports division.

Bega Cheese holds back in three-way bidding war for WCB

The Age 19/12/2013 | Bega Cheese began the battle for Warrnambool Cheese & Butter but three months on it appears to be the first casualty of the bidding war.

Aussie hampers transition

The Age 19/12/2013 | A persistently high Australian dollar is thwarting the Reserve Bank's efforts to ease the transition of the economy away from mining.

RBA keeps its focus on lower dollar

The Age 19/12/2013 | The Reserve Bank is keeping the door open to further interest rate cuts, but believes the "significant amount" of monetary policy easing over the past two years is already stimulating growth.

Pact's struggles weigh down Orora

The Age 19/12/2013 | The underwhelming sharemarket debut of packaging company Pact Group Holdings has weighed on the demerger of Amcor and its $2 billion Australasian packaging and distribution business Orora.


Sponsored Links